|
| US-MA, Senior Manager, Vaccine Market Research |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Sr. Director, Outcomes Research |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Associate Director, IBD Market and Customer Insights |
Takeda Pharmaceuticals | 4/25/2019 |
| United States, Director Global HEOR |
ProClinical | 4/25/2019 |
| US-MA, Associate Director, Outcomes Research and Data Science |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Associate Director, Outcomes Research and Data Science |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Head of Research, Global Medical Affairs Oncology |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Head of Plasma-Derived Therapies (PDT) Translational Research |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Market Research Insights Lead |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Senior Manager, BU Insights |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Market Research Insights Manager |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Senior Manager, BU Insights |
Takeda Pharmaceuticals | 4/25/2019 |
| US-CA, Medical Director/ Senior Medical Director, Translational Medicine Neuroscience (NS) |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Associate Director, Global Oncology Market Insights |
Takeda Pharmaceuticals | 4/25/2019 |
| US-CA, Associate Director - In Vitro Pharmacology CNS - San Diego, CA |
Takeda Pharmaceuticals | 4/25/2019 |
| US-CT, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-NY, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-MA, Lead, Human Factors Engineering |
Takeda Pharmaceuticals | 4/25/2019 |
| US-NJ, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-IL, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-IN, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-MA, Head, Immuno-Oncology Research |
Takeda Pharmaceuticals | 4/25/2019 |
| US-NC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-MA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-FL, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-IL, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-NY, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-MA, Senior Scientific Director, Hematology and Rare Disease |
Takeda Pharmaceuticals | 4/25/2019 |
| US-SC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-PA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-MA, Lead, Human Factors Engineering |
Takeda Pharmaceuticals | 4/25/2019 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-NC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-PA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-NJ, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-FL, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-MA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-NC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-CT, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-SC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-NC, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-MA, Head, Strategy & Research, Neuroinflammation |
Takeda Pharmaceuticals | 4/25/2019 |
| US-MA, Associate Director/Principle Scientist - Gene Therapy |
Takeda Pharmaceuticals | 4/25/2019 |
| US-CA, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
EPM Scientific | 4/25/2019 |
| US-IN, Clinical Research Associate – Oncology – Phase II and Phase III Trials |
Phaidon International | 4/25/2019 |
| US-MA, Senior Medical Director, Rare Disease |
Takeda Pharmaceuticals | 4/25/2019 |
Didn't Find What You're Looking For?
|